Answers are grounded in this paper and cite their sources.
Case report details the development of Fanconi syndrome and peripheral neuropathy due to adefovir dipivoxil, suggesting a need for monitoring.
Long-term use of low-dose adefovir dipivoxil (ADV) has been increasingly associated with Fanconi syndrome; however, cases of Fanconi syndrome combined with peripheral neuropathy remain rare. Here, we report a 67-year-old man who developed progressive limb weakness and sensory abnormalities after approximately 6 years of treatment with 10 mg ADV. He was diagnosed with ADV-associated Fanconi syndrome accompanied by peripheral neuropathy. Following the substitution of ADV with entecavir and 5 months to 6 months of phosphate supplementation, the patient’s muscle weakness nearly resolved, and peripheral nerve damage showed significant improvement.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: